| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TransMedics Group, Inc. | Director | Common Stock | 155K | $14.3M | $92.43 | May 22, 2025 | By the James R. Tobin 2012 Trust |
| TransMedics Group, Inc. | Director | Common Stock | 18K | $1.66M | $92.43 | May 22, 2025 | By The Tobin 2024 Family Trust |
| TransMedics Group, Inc. | Director | Common Stock | 4.06K | $375K | $92.43 | May 22, 2025 | Direct |
| Lyra Therapeutics, Inc. | Director | Restricted Stock Units | 32K | May 14, 2025 | Direct | ||
| Lyra Therapeutics, Inc. | Director | Stock Option | 30K | Jun 13, 2024 | Direct | ||
| GLOBUS MEDICAL INC | Director | Stock Option (Right to Buy Class A Common Stock) | 15K | Jan 23, 2025 | Direct | ||
| TransMedics Group, Inc. | Director | Stock Option (Right to Buy) | 1.15K | May 23, 2024 | Direct |